Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS colonisation of vaginal epithelial cells. (2022)
Attributed to:
BactiVac
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2022.08.064
PubMed Identifier: 36096970
Publication URI: http://europepmc.org/abstract/MED/36096970
Type: Journal Article/Review
Volume: 40
Parent Publication: Vaccine
Issue: 42
ISSN: 0264-410X